Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
ADC maps
Meningioma
Radiomic features
SUVmax
[68Ga]Ga-DOTATOC PET
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
03
07
2023
accepted:
03
08
2023
medline:
6
11
2023
pubmed:
14
9
2023
entrez:
14
9
2023
Statut:
ppublish
Résumé
This retrospective study aimed to analyse the correlation between somatostatin receptor subtypes (SSTR 1-5) and maximum standardized uptake value (SUV The study included 51 patients who underwent MRI and [68Ga]Ga-DOTATOC PET before meningioma surgery. SUV The random forest regression model successfully predicted SUV SSTR subtypes 2A, 2B, and 5 correlated significantly with SUV
Identifiants
pubmed: 37707754
doi: 10.1007/s11060-023-04414-3
pii: 10.1007/s11060-023-04414-3
pmc: PMC10589159
doi:
Substances chimiques
Edotreotide
U194AS08HZ
Octreotide
RWM8CCW8GP
Receptors, Somatostatin
0
Organometallic Compounds
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
711-720Informations de copyright
© 2023. The Author(s).
Références
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–391. https://doi.org/10.1016/s1470-2045(16)30321-7
doi: 10.1016/s1470-2045(16)30321-7
pubmed: 27599143
Afshar-Oromieh A, Giesel FL, Linhart HG, Haberkorn U, Haufe S, Combs SE, Podlesek D, Eisenhut M, Kratochwil C (2012) Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging 39:1409–1415. https://doi.org/10.1007/s00259-012-2155-3
doi: 10.1007/s00259-012-2155-3
pubmed: 22669255
Pieper DR, Al-Mefty O (1999) Management of intracranial meningiomas secondarily involving the infratemporal fossa: radiographic characteristics, pattern of tumor invasion, and surgical implications. Neurosurgery 45: 231–237; discussion 237–238 doi: https://doi.org/10.1097/00006123-199908000-00005
Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC (1998) Expression of somatostatin receptor subtypes in human brain tumors. Int J cancer J Int du cancer 76:620–627
doi: 10.1002/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S
Reubi JC, Maurer R, Klijn JG, Stefanko SZ, Foekens JA, Blaauw G, Blankenstein MA, Lamberts SW (1986) High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab 63:433–438. https://doi.org/10.1210/jcem-63-2-433
doi: 10.1210/jcem-63-2-433
pubmed: 3013920
Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T (2015) Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol 130:441–443. https://doi.org/10.1007/s00401-015-1459-3
doi: 10.1007/s00401-015-1459-3
pubmed: 26195322
Kunz WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, Bollenbacher A, Tonn JC, Schichor C, Rominger A, Albert NL, Bartenstein P, Reiser MF, Cyran CC (2017) Improved detection of Transosseous Meningiomas using (68)Ga-DOTATATE PET/CT compared with contrast-enhanced MRI. Journal of nuclear medicine: official publication. Soc Nuclear Med 58:1580–1587. https://doi.org/10.2967/jnumed.117.191932
doi: 10.2967/jnumed.117.191932
Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Pöschl J, Schüller U, Schichor C, Thon N, Tonn JC (2015) Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J nuclear medicine: official publication Soc Nuclear Med 56:347–353. https://doi.org/10.2967/jnumed.114.149120
doi: 10.2967/jnumed.114.149120
Sommerauer M, Burkhardt JK, Frontzek K, Rushing E, Buck A, Krayenbuehl N, Weller M, Schaefer N, Kuhn FP (2016) 68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate? Neuro Oncol 18:1021–1027. https://doi.org/10.1093/neuonc/now001
doi: 10.1093/neuonc/now001
pubmed: 26865086
pmcid: 4896546
Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U, Debus J (2006) Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 65:222–227. https://doi.org/10.1016/j.ijrobp.2005.12.006
doi: 10.1016/j.ijrobp.2005.12.006
pubmed: 16488553
Graf R, Nyuyki F, Steffen IG, Michel R, Fahdt D, Wust P, Brenner W, Budach V, Wurm R, Plotkin M (2013) Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. Int J Radiat Oncol Biol Phys 85:68–73. https://doi.org/10.1016/j.ijrobp.2012.03.021
doi: 10.1016/j.ijrobp.2012.03.021
pubmed: 22575489
Nyuyki F, Plotkin M, Graf R, Michel R, Steffen I, Denecke T, Geworski L, Fahdt D, Brenner W, Wurm R (2010) Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas. Eur J Nucl Med Mol Imaging 37:310–318. https://doi.org/10.1007/s00259-009-1270-2
doi: 10.1007/s00259-009-1270-2
pubmed: 19763565
Gehler B, Paulsen F, Oksüz MO, Hauser TK, Eschmann SM, Bares R, Pfannenberg C, Bamberg M, Bartenstein P, Belka C, Ganswindt U (2009) [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol 4:56. https://doi.org/10.1186/1748-717x-4-56
doi: 10.1186/1748-717x-4-56
pubmed: 19922642
pmcid: 2785827
Thie JA (2004) Understanding the standardized uptake value, its methods, and implications for usage. J nuclear medicine: official publication Soc Nuclear Med 45:1431–1434
Miederer M, Seidl S, Buck A, Scheidhauer K, Wester HJ, Schwaiger M, Perren A (2009) Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 36:48–52. https://doi.org/10.1007/s00259-008-0944-5
doi: 10.1007/s00259-008-0944-5
pubmed: 18807033
Zakaria R, Das K, Bhojak M, Radon M, Walker C, Jenkinson MD (2014) The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging 14:8. https://doi.org/10.1186/1470-7330-14-8
doi: 10.1186/1470-7330-14-8
pubmed: 25608557
pmcid: 4331840
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577. https://doi.org/10.1148/radiol.2015151169
doi: 10.1148/radiol.2015151169
pubmed: 26579733
Gu H, Zhang X, di Russo P, Zhao X, Xu T (2020) The current state of Radiomics for Meningiomas: promises and challenges. Front Oncol 10:567736. https://doi.org/10.3389/fonc.2020.567736
doi: 10.3389/fonc.2020.567736
pubmed: 33194649
pmcid: 7653049
Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, Makino K, Nakamura H, Ikushima I, Yamura M, Kochi M, Kuratsu JI, Yamashita Y (2006) Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27:1419–1425
pubmed: 16908550
pmcid: 7977525
Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505. https://doi.org/10.1148/radiology.168.2.3393671
doi: 10.1148/radiology.168.2.3393671
pubmed: 3393671
Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, Woehrer A, Hackl M, Widhalm G, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M (2013) Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times. PLoS ONE 8:e55464. https://doi.org/10.1371/journal.pone.0055464
doi: 10.1371/journal.pone.0055464
pubmed: 23393579
pmcid: 3564927
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4
doi: 10.1007/s00401-007-0243-4
pubmed: 17618441
pmcid: 1929165
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016/05/10 edn., 803–820
Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, Virgolini I, Haubner R (2007) A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 28:870–875. https://doi.org/10.1097/MNM.0b013e3282f1753d
doi: 10.1097/MNM.0b013e3282f1753d
pubmed: 17901771
Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ (2013) Somatostatin receptor PET in neuroendocrine tumours: (68)Ga-DOTA (0),tyr (3)-octreotide versus (68)Ga-DOTA (0)-lanreotide. Eur J Nucl Med Mol Imaging 40:364–372. https://doi.org/10.1007/s00259-012-2286-6
doi: 10.1007/s00259-012-2286-6
pubmed: 23151915
Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ (1995) Spatial Registration and normalization of images. Hum Brain Mapp 2:165–189
doi: 10.1002/hbm.460030303
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 31:1116–1128. https://doi.org/10.1016/j.neuroimage.2006.01.015
doi: 10.1016/j.neuroimage.2006.01.015
pubmed: 16545965
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts HJWL (2017) Computational Radiomics System to Decode the Radiographic phenotype. Cancer Res 77:e104–e107
doi: 10.1158/0008-5472.CAN-17-0339
pubmed: 29092951
pmcid: 5672828
Wright MN, Ziegler A (2017) Ranger: a fast implementation of Random forests for high Dimensional Data in C + + and R. J Stat Softw 77:1–17. https://doi.org/10.18637/jss.v077.i01
doi: 10.18637/jss.v077.i01
Peng HC, Long FH, Ding C (2005) Feature selection based on mutual information: Criteria of max-dependency, max-relevance, and min-redundancy. Ieee T Pattern Anal 27:1226–1238. https://doi.org/10.1109/Tpami.2005.159
doi: 10.1109/Tpami.2005.159
Kuhn M (2008) Building Predictive Models in R Using the caret Package. Journal of Statistical Software, Foundation for Open Access Statistics vol. 28(i05)
De Jay N, Papillon-Cavanagh S, Olsen C, El-Hachem N, Bontempi G, Haibe-Kains B (2013) mRMRe: an R package for parallelized mRMR ensemble feature selection. Bioinf (Oxford England) 29:2365–2368. https://doi.org/10.1093/bioinformatics/btt383
doi: 10.1093/bioinformatics/btt383
Max Kuhn. Contributions from, Jed Wing SW, Andre Williams C, Keefer A, Engelhardt T, Cooper Z, Mayer (2016) Brenton Kenkel, the R Core Team, Michael Benesty, Reynald Lescarbeau, Andrew Ziem, Luca Scrucca, Yuan Tang and Can Candan. Classification and Regression Training. R package version 6.0–7
Team RC (2022) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
Corp I (2019) IBM SPSS Statistics for Windows. IBM Corp, Armonk, NY. Version 26.0
Remmele W, Stegner HE (1987) [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8:138–140
pubmed: 3303008
Kim SH, Roytman M, Madera G, Magge RS, Liechty B, Ramakrishna R, Pannullo SC, Schwartz TH, Karakatsanis NA, Osborne JR, Lin E, Knisely JPS, Ivanidze J (2022) Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET/MRI analysis in patients with meningioma. Sci Rep 12:9256. https://doi.org/10.1038/s41598-022-13467-9
doi: 10.1038/s41598-022-13467-9
pubmed: 35661809
pmcid: 9166786
Hänscheid H, Sweeney RA, Flentje M, Buck AK, Löhr M, Samnick S, Kreissl M, Verburg FA (2012) PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma. Eur J Nucl Med Mol Imaging 39:1284–1288. https://doi.org/10.1007/s00259-012-2124-x
doi: 10.1007/s00259-012-2124-x
pubmed: 22526964
Behling F, Fodi C, Skardelly M, Renovanz M, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J (2022) Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential. Neurosurg Rev 45:467–478. https://doi.org/10.1007/s10143-021-01552-y
doi: 10.1007/s10143-021-01552-y
pubmed: 33899156
Fodi C, Skardelly M, Hempel JM, Hoffmann E, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J, Behling F (2022) The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma. Neurosurg Rev 45:2671–2679. https://doi.org/10.1007/s10143-021-01651-w
doi: 10.1007/s10143-021-01651-w
pubmed: 34601710
Gerster-Gilliéron K, Forrer F, Maecke H, Mueller-Brand J, Merlo A, Cordier D (2015) 90Y-DOTATOC as a therapeutic option for Complex Recurrent or Progressive Meningiomas. Journal of nuclear medicine: official publication. Soc Nuclear Med 56:1748–1751. https://doi.org/10.2967/jnumed.115.155853
doi: 10.2967/jnumed.115.155853
Hartrampf PE, Hänscheid H, Kertels O, Schirbel A, Kreissl MC, Flentje M, Sweeney RA, Buck AK, Polat B, Lapa C (2020) Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma. Clin translational radiation Oncol 22:29–32. https://doi.org/10.1016/j.ctro.2020.03.002
doi: 10.1016/j.ctro.2020.03.002
Seystahl K, Stoecklein V, Schüller U, Rushing E, Nicolas G, Schäfer N, Ilhan H, Pangalu A, Weller M, Tonn JC, Sommerauer M, Albert NL (2016) Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. Neuro Oncol 18:1538–1547. https://doi.org/10.1093/neuonc/now060
doi: 10.1093/neuonc/now060
pubmed: 27106404
pmcid: 5063513
Kandemirli SG, Chopra S, Priya S, Ward C, Locke T, Soni N, Srivastava S, Jones K, Bathla G (2020) Presurgical detection of brain invasion status in meningiomas based on first-order histogram based texture analysis of contrast enhanced imaging. Clin Neurol Neurosurg 198:106205. https://doi.org/10.1016/j.clineuro.2020.106205
doi: 10.1016/j.clineuro.2020.106205
pubmed: 32932028
Haralick RM, Shanmugam K, Dinstein I (1973) Textural features for image classification. IEEE Trans Syst Man Cybernetics SMC –3:610–621. https://doi.org/10.1109/TSMC.1973.4309314
doi: 10.1109/TSMC.1973.4309314
Xiao D, Zhao Z, Liu J, Wang X, Fu P, Le Grange JM, Wang J, Guo X, Zhao H, Shi J, Yan P, Jiang X (2021) Diagnosis of Invasive Meningioma based on brain-tumor interface Radiomics features on brain MR images: a Multicenter Study. Front Oncol 11. https://doi.org/10.3389/fonc.2021.708040
Tamal M (2019) Grey Level Co-occurrence Matrix (GLCM) as a Radiomics feature for Artificial Intelligence (AI) assisted Positron Emission Tomography (PET) images analysis. IOP Conf Series: Mater Sci Eng 646:012047. https://doi.org/10.1088/1757-899X/646/1/012047
doi: 10.1088/1757-899X/646/1/012047
Moon C-M, Lee YY, Kim D-Y, Yoon W, Baek BH, Park J-H, Heo S-H, Shin S-S, Kim SK (2023) Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model. Front Oncol 13. https://doi.org/10.3389/fonc.2023.1138069
Duan C, Li N, Li Y, Cui J, Xu W, Liu X (2023) Prediction of progesterone receptor expression in high-grade meningioma by using radiomics based on enhanced T1WI. https://doi.org/10.1016/j.crad.2023.06.006 . Clinical radiology doi:
Friconnet G, Baudouin M, Brinjikji W, Saleme S, Espíndola Ala VH, Boncoeur-Martel M-P, Mounayer C, Rouchaud A (2022) Advanced MRI shape analysis as a predictor of histologically aggressive supratentorial meningioma. J Neuroradiol 49:275–280. https://doi.org/10.1016/j.neurad.2020.12.007
doi: 10.1016/j.neurad.2020.12.007
pubmed: 33421448
Yan P-F, Yan L, Hu T-T, Xiao D-D, Zhang Z, Zhao H-Y, Feng J (2017) The potential value of preoperative MRI texture and shape analysis in Grading Meningiomas: a preliminary investigation. Translational Oncol 10:570–577. https://doi.org/10.1016/j.tranon.2017.04.006
doi: 10.1016/j.tranon.2017.04.006
Laukamp KR, Shakirin G, Baessler B, Thiele F, Zopfs D, Grosse Hokamp N, Timmer M, Kabbasch C, Perkuhn M, Borggrefe J (2019) Accuracy of Radiomics-Based feature analysis on Multiparametric magnetic resonance images for Noninvasive Meningioma Grading. World Neurosurg 132:e366–e390. https://doi.org/10.1016/j.wneu.2019.08.148
doi: 10.1016/j.wneu.2019.08.148
pubmed: 31476455
Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, Turgutlu K, Bush NAO, Solberg TD, Braunstein SE, Sneed PK, Perry A, Zadeh G, McDermott MW, Villanueva-Meyer JE, Raleigh DR (2019) Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neuro-oncology Adv 1:vdz011. https://doi.org/10.1093/noajnl/vdz011
doi: 10.1093/noajnl/vdz011
Lu Y, Liu L, Luan S, Xiong J, Geng D, Yin B (2019) The diagnostic value of texture analysis in predicting WHO grades of meningiomas based on ADC maps: an attempt using decision tree and decision forest. Eur Radiol 29:1318–1328. https://doi.org/10.1007/s00330-018-5632-7
doi: 10.1007/s00330-018-5632-7
pubmed: 30088065
Ugga L, Perillo T, Cuocolo R, Stanzione A, Romeo V, Green R, Cantoni V, Brunetti A (2021) Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis. Neuroradiology 63:1293–1304. https://doi.org/10.1007/s00234-021-02668-0
doi: 10.1007/s00234-021-02668-0
pubmed: 33649882
pmcid: 8295153
Park CJ, Choi SH, Eom J, Byun HK, Ahn SS, Chang JH, Kim SH, Lee S-K, Park YW, Yoon HI (2022) An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas. Radiat Oncol 17:147. https://doi.org/10.1186/s13014-022-02090-7
doi: 10.1186/s13014-022-02090-7
pubmed: 35996160
pmcid: 9396861
Lecchi M, Fossati P, Elisei F, Orecchia R, Lucignani G (2008) Current concepts on imaging in radiotherapy. Eur J Nucl Med Mol Imaging 35:821–837. https://doi.org/10.1007/s00259-007-0631-y
doi: 10.1007/s00259-007-0631-y
pubmed: 17972074